33 results on '"Chen, Zhe-Sheng"'
Search Results
2. Epigenetic modification of m6A regulator proteins in cancer
3. Gold nanoparticles and gold nanorods in the landscape of cancer therapy
4. Advancements in nanoparticle-based treatment approaches for skin cancer therapy
5. New opportunities for RGD-engineered metal nanoparticles in cancer
6. Bridging cultures: Chinese elements in scientific illustrations
7. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN
8. PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study
9. m6A modification: recent advances, anticancer targeted drug discovery and beyond
10. Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma
11. CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells
12. Proteomics technologies for cancer liquid biopsies
13. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
14. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
15. Isolation, bioassay and 3D-QSAR analysis of 8-isopentenyl flavonoids from Epimedium sagittatum maxim. as PDE5A inhibitors
16. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p
17. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma
18. Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
19. MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
20. Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
21. Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer
22. Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing
23. Long non-coding RNAs regulate drug resistance in cancer
24. The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
25. Epigenetic modification of m6A regulator proteins in cancer.
26. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
27. Autophagy and multidrug resistance in cancer.
28. The reversal of antineoplastic drug resistance in cancer cells by β-elemene.
29. ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel.
30. Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs.
31. Overexpression of P-glycoprotein induces acquired resistance to imatinib in chronic myelogenous leukemia cells.
32. Multidrug resistance associated proteins in multidrug resistance.
33. Role of ABC transporters in cancer chemotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.